Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Med.

Sec. Pulmonary Medicine

Volume 12 - 2025 | doi: 10.3389/fmed.2025.1654729

Correction: Serum concentrations of Krebs von den Lungen-6 as prognostic biomarker in patients with silicosis

Provisionally accepted
Raluca Andreea SmarandescuRaluca Andreea Smarandescu1Marina Ruxandra OteleaMarina Ruxandra Otelea1,2Eugenia PanaitescuEugenia Panaitescu3*Andrä JitkaAndrä Jitka4Francesco BonellaFrancesco Bonella4Agripina RascuAgripina Rascu1,2
  • 1Clinical Department 5, Internal Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
  • 2Department of Occupational Medicine, Spitalul Clinic Colentina, Bucharest, Romania
  • 3Department 3 - Complementary Sciences, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
  • 4Pneumology, Center for Interstitial and Rare Lung Disease, Department of Pneumology, Ruhrlandklinik University Hospital, University of Duisburg-Essen, Essen, Germany, Essen, Germany

This article is a correction to:

  1. Serum concentrations of Krebs von den Lungen-6 as prognostic biomarker in patients with silicosis

    1. Read original article

The final, formatted version of the article will be published soon.

Select one of your emails

You have multiple emails registered with Frontiers:

Notify me on publication

Please enter your email address:

If you already have an account, please login

You don't have a Frontiers account ? You can register here

Incorrect funding Funder name incorrectAn incorrect Funding statement was provided. The correct funding statement reads:“Publication of this paper was supported by the University of Medicine and Pharmacy Carol Davila, through the institutional program Publish not Perish”.The original version of this article has been updated.AcknowledgementsIn the acknowledgements, the following text is missing from the Acknowledgements section: “Publication of this paper was supported by the University of Medicine and Pharmacy Carol Davila, through the institutional program Publish not Perish”.The original version of this article has been updated.

Keywords: KL-6, Silicosis, occupational fibrosis, Crystalline silica, biomarker, disease progression

Received: 26 Jun 2025; Accepted: 04 Jul 2025.

Copyright: © 2025 Smarandescu, Otelea, Panaitescu, Jitka, Bonella and Rascu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Eugenia Panaitescu, Department 3 - Complementary Sciences, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Supplementary Material